Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Disease 1 COVID-19 1

Interventions

Standard of Care 8 Surveys and Questionnaires 7 COVID-19 Vaccines 6 Blood Specimen Collection 6 BNT162 Vaccine 6 Specimen Handling 5 2019-nCoV Vaccine mRNA-1273 5 Hydroxychloroquine 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Sodium Chloride 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Serologic Tests × Clear all

NCT04345315 2020-04-15

CORSA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡